Breaking News: Applied Therapeutics Inc. Faces Lawsuit for Securities Law Violations – What Investors Need to Know
LOS ANGELES, CA / ACCESSWIRE / December 28, 2024
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before February 18, 2025.
Applied Therapeutics Inc. is currently facing a lawsuit for securities law violations, and investors need to be aware of the potential implications. The lawsuit alleges that the company violated sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5 promulgated by the U.S. Securities and Exchange Commission. This news comes as a shock to many investors who may have purchased securities in the company during the Class Period, which spans from January 3, 2024, to December 2, 2024.
Securities law violations can have serious consequences for both investors and the company involved. In this case, investors may have suffered financial losses as a result of the alleged violations by Applied Therapeutics Inc. It is important for investors to be aware of their rights and options in such situations, which is why the Schall Law Firm is reminding investors of this class action lawsuit.
Investors who purchased Applied Therapeutics Inc. securities during the Class Period are encouraged to contact the Schall Law Firm before February 18, 2025. By doing so, investors can learn more about the lawsuit and potential recovery options available to them. It is essential for investors to stay informed and take appropriate action to protect their investments.
How will this affect me?
If you are an investor who purchased securities in Applied Therapeutics Inc. between January 3, 2024, and December 2, 2024, you may be affected by the class action lawsuit for securities law violations. It is important to contact the Schall Law Firm before February 18, 2025, to learn more about your rights and potential recovery options. By staying informed and taking appropriate action, you can protect your investments and potentially recover from any financial losses suffered as a result of the alleged violations by the company.
How will this affect the world?
The lawsuit against Applied Therapeutics Inc. for securities law violations highlights the importance of corporate transparency and accountability in the global financial market. Securities laws are in place to protect investors and ensure fair and honest trading practices. When companies violate these laws, it can damage investor trust, impact financial markets, and erode overall market integrity. This case serves as a reminder of the need for vigilant oversight and enforcement of securities laws to maintain a level playing field for all investors and uphold market integrity.
Conclusion
In conclusion, the class action lawsuit against Applied Therapeutics Inc. for securities law violations underscores the importance of investor awareness and corporate accountability. Investors who purchased the company’s securities during the Class Period should take action to protect their investments and learn about potential recovery options. Additionally, this case highlights the broader implications of securities law violations on the global financial market, emphasizing the need for transparency, oversight, and enforcement to uphold investor trust and market integrity.
